Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial

MLA

Arsene Mekinian, et al. “Tocilizumab in Treatment-Naïve Patients with Takayasu Arteritis: TOCITAKA French Prospective Multicenter Open-Labeled Trial.” Arthritis Research & Therapy, vol. 22, no. 1, Sept. 2020, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s13075-020-02311-y.

APA

Arsene Mekinian, David Saadoun, Eric Vicaut, Sara Thietart, Bertrand Lioger, Patrick Jego, Alexandre Bleibtreu, Nicolas Limal, Jerome Connault, Jacques-Eric Gottenberg, Pauline Lhorte, Jean Pierre Bertola, Juliette Delforge, Nicole Ferreira-Maldent, Antoinette Perlat, Zohra Talib, Matthieu Vautier, Léa Savey, Isabelle Quiere, … for the French Takayasu network. (2020). Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial. Arthritis Research & Therapy, 22(1), 1–7. https://doi.org/10.1186/s13075-020-02311-y

Chicago

Arsene Mekinian, David Saadoun, Eric Vicaut, Sara Thietart, Bertrand Lioger, Patrick Jego, Alexandre Bleibtreu, et al. 2020. “Tocilizumab in Treatment-Naïve Patients with Takayasu Arteritis: TOCITAKA French Prospective Multicenter Open-Labeled Trial.” Arthritis Research & Therapy 22 (1): 1–7. doi:10.1186/s13075-020-02311-y.